A condition in which the percentage of progressively motile sperm is abnormally low. In men, it is defined as <25% rapid motility or <50% progression in a semen sample (World Health Organization, 1992).
Networked: 213 relevant articles (14 outcomes, 38 trials/studies) for this Disease, Comments

Relationship Network

Disease Context: Research Results

Related Diseases

1. Oligospermia (Oligozoospermia)
2. Male Infertility (Male Sterility)
3. Infertility (Sterility)
4. Hyperprolactinemia
5. Chromosome Aberrations (Chromosome Abnormalities)


1. Balercia, Giancarlo: 8 articles (11/2014 - 01/2004)
2. Vignini, Arianna: 5 articles (11/2014 - 05/2009)
3. Lenzi, Andrea: 5 articles (11/2014 - 06/2004)
4. Buldreghini, Eddi: 5 articles (11/2014 - 05/2009)
5. Salvolini, Eleonora: 3 articles (11/2014 - 03/2012)
6. Lucarini, Guendalina: 3 articles (11/2014 - 03/2012)
7. Di Primio, Roberto: 3 articles (11/2014 - 03/2012)
8. Mostafa, Taymour: 3 articles (05/2013 - 11/2006)
9. Ricciardo-Lamonica, Giuseppe: 3 articles (09/2010 - 01/2004)
10. Tiano, Luca: 3 articles (03/2010 - 11/2005)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Asthenozoospermia:
1. Kallikreins (Kallikrein)IBA
2. coenzyme Q10 (CoQ10)IBA
3. UbiquinoneIBA
4. ubiquinolIBA
5. Carnitine (L-Carnitine)FDA LinkGeneric
6. TamoxifenFDA LinkGeneric
7. Clomiphene (Clomifene)FDA LinkGeneric
8. Sulpiride (neogama)IBA
9. Ketotifen (Ketotifene)FDA Link
10. Male Contraceptive Agents (Male Contraceptives)IBA

Therapies and Procedures

1. Aftercare (After-Treatment)
2. Contraception (Birth Control)
3. Oral Administration
4. Vasectomy (Vas Occlusion)
5. Chinese Traditional Medicine (Traditional Chinese Medicine)

blog comments powered by Disqus
for Asthenozoospermia,
Ranking and Evidence
*WARNING* This specific disease subtype has a relatively small number of significant evidence outcomes. You may proceed to order anyway, or go back to the search field and enter a more general type of the target illness. Once your report has been ordered, however, we can't refund the purchase.

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. Analytic charts allow you and your physicians to see at a glance the treatment options—including new, promising, off-label and experimental.
  • Free Updates for 1 Year
  • All 14 Outcomes
  • Top 200 Key Drugs and Biologics
  • Top 9 Key Therapies and Procedures
  • Detailed History Charts
  • Full Research Evidence References
  • Sample PDF Report on Psoriasis >>
Price:$24.95 USD & Delivery via PDF download
updates for 1 year
Research Interface PRO

Rapidly retrieve clinical outcome summaries for all evidence of drug efficacy against any disease in seconds. Click "Charts" to view graphs of relative efficacy of all drugs against any known disease. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time. Save hours of search and analysis time:
Price:$490.00 USD access via web interface
1 year subscription
Request Bulk Institution License Details >>